Gene Symbol | Gene ID | Gene Info |
---|---|---|
TP63
|
ENSG00000073282.8 | tumor protein p63 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_189230113_189230264 | TP63 | 119028 | 0.065634 | 0.82 | 7.2e-03 | Click! |
chr3_189348874_189349088 | TP63 | 235 | 0.964470 | -0.81 | 8.0e-03 | Click! |
chr3_189489895_189490046 | TP63 | 17479 | 0.260572 | 0.81 | 8.1e-03 | Click! |
chr3_189307292_189307443 | TP63 | 41849 | 0.215907 | 0.78 | 1.3e-02 | Click! |
chr3_189347931_189348281 | TP63 | 1110 | 0.678877 | -0.78 | 1.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_164680910_164681061 | 6.11 |
RP11-477H21.2 |
|
31663 |
0.17 |
chr11_69214033_69214458 | 5.75 |
MYEOV |
myeloma overexpressed |
152620 |
0.04 |
chr17_77023308_77023681 | 5.61 |
C1QTNF1-AS1 |
C1QTNF1 antisense RNA 1 |
189 |
0.91 |
chr7_134200953_134201104 | 4.75 |
AKR1B10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
11316 |
0.22 |
chr2_25328918_25329203 | 4.23 |
EFR3B |
EFR3 homolog B (S. cerevisiae) |
9797 |
0.2 |
chr10_4584081_4584405 | 4.21 |
ENSG00000207124 |
. |
27099 |
0.26 |
chr5_9467732_9467883 | 4.05 |
CTD-2201E9.2 |
|
55483 |
0.13 |
chr18_9825118_9825470 | 3.89 |
ENSG00000242651 |
. |
5330 |
0.21 |
chr3_134383216_134383367 | 3.89 |
KY |
kyphoscoliosis peptidase |
13427 |
0.23 |
chr21_40365890_40366069 | 3.78 |
ENSG00000272015 |
. |
99270 |
0.07 |
chr12_125167837_125167988 | 3.77 |
NCOR2 |
nuclear receptor corepressor 2 |
115902 |
0.06 |
chr21_36077113_36077512 | 3.72 |
CLIC6 |
chloride intracellular channel 6 |
35624 |
0.17 |
chr16_89666849_89667000 | 3.71 |
CPNE7 |
copine VII |
4940 |
0.12 |
chr20_25003716_25003867 | 3.69 |
ACSS1 |
acyl-CoA synthetase short-chain family member 1 |
9517 |
0.19 |
chr7_44454046_44454197 | 3.65 |
NUDCD3 |
NudC domain containing 3 |
76358 |
0.08 |
chr10_73769753_73769963 | 3.61 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
45735 |
0.15 |
chr11_126242895_126243350 | 3.56 |
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
17253 |
0.15 |
chr4_113331637_113331788 | 3.56 |
RP11-402J6.1 |
|
104829 |
0.06 |
chr11_36720985_36721136 | 3.54 |
RAG2 |
recombination activating gene 2 |
101274 |
0.07 |
chr21_43085496_43085711 | 3.51 |
LINC00112 |
long intergenic non-protein coding RNA 112 |
50993 |
0.12 |
chr2_201652506_201652946 | 3.50 |
ENSG00000201737 |
. |
12419 |
0.12 |
chr17_25887372_25887653 | 3.50 |
KSR1 |
kinase suppressor of ras 1 |
22435 |
0.19 |
chr9_37913378_37913679 | 3.46 |
SLC25A51 |
solute carrier family 25, member 51 |
9398 |
0.22 |
chr6_2103859_2104525 | 3.46 |
GMDS |
GDP-mannose 4,6-dehydratase |
72033 |
0.13 |
chr1_113424797_113425028 | 3.42 |
SLC16A1 |
solute carrier family 16 (monocarboxylate transporter), member 1 |
53698 |
0.13 |
chr6_1637910_1638061 | 3.39 |
FOXC1 |
forkhead box C1 |
27304 |
0.25 |
chr8_13124406_13124699 | 3.38 |
DLC1 |
deleted in liver cancer 1 |
9503 |
0.27 |
chr7_1600035_1600318 | 3.37 |
TMEM184A |
transmembrane protein 184A |
281 |
0.89 |
chr16_84210365_84210716 | 3.31 |
DNAAF1 |
dynein, axonemal, assembly factor 1 |
793 |
0.49 |
chr17_42426285_42426667 | 3.29 |
GRN |
granulin |
1431 |
0.24 |
chr6_33558663_33558814 | 3.25 |
LINC00336 |
long intergenic non-protein coding RNA 336 |
2377 |
0.2 |
chr16_70715866_70716017 | 3.22 |
MTSS1L |
metastasis suppressor 1-like |
2013 |
0.25 |
chr7_1979016_1979224 | 3.22 |
MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
1065 |
0.63 |
chr15_59586966_59587117 | 3.21 |
RP11-429D19.1 |
|
23680 |
0.13 |
chr6_111894350_111894541 | 3.20 |
TRAF3IP2-AS1 |
TRAF3IP2 antisense RNA 1 |
1377 |
0.41 |
chr17_55059842_55059993 | 3.18 |
RP5-1107A17.4 |
|
193 |
0.91 |
chr5_14463844_14464298 | 3.17 |
TRIO |
trio Rho guanine nucleotide exchange factor |
24486 |
0.26 |
chr6_161454710_161454940 | 3.16 |
MAP3K4 |
mitogen-activated protein kinase kinase kinase 4 |
11599 |
0.25 |
chr9_16530797_16530948 | 3.14 |
RP11-183I6.2 |
|
57686 |
0.14 |
chr3_154512727_154512878 | 3.12 |
MME |
membrane metallo-endopeptidase |
229111 |
0.02 |
chr2_102136508_102136659 | 3.12 |
RFX8 |
RFX family member 8, lacking RFX DNA binding domain |
45418 |
0.18 |
chr3_9216538_9216718 | 3.10 |
SRGAP3-AS2 |
SRGAP3 antisense RNA 2 |
17549 |
0.2 |
chr2_70008722_70008880 | 3.08 |
ANXA4 |
annexin A4 |
39565 |
0.14 |
chr9_33447775_33448432 | 3.02 |
AQP3 |
aquaporin 3 (Gill blood group) |
494 |
0.76 |
chr22_30658207_30658358 | 3.00 |
OSM |
oncostatin M |
3525 |
0.13 |
chr22_20051623_20051921 | 3.00 |
AC006547.15 |
|
1456 |
0.19 |
chr19_43882764_43882915 | 2.98 |
CTC-490G23.4 |
|
9717 |
0.15 |
chr9_129467103_129467282 | 2.97 |
ENSG00000266403 |
. |
13420 |
0.21 |
chr10_104438682_104439075 | 2.96 |
TRIM8 |
tripartite motif containing 8 |
34234 |
0.11 |
chr17_66449042_66449331 | 2.94 |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
4376 |
0.23 |
chr3_52380882_52381033 | 2.94 |
DNAH1 |
dynein, axonemal, heavy chain 1 |
30622 |
0.09 |
chr17_2162360_2162742 | 2.92 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
6874 |
0.12 |
chr3_78968730_78968881 | 2.92 |
ENSG00000240964 |
. |
18637 |
0.29 |
chr6_42207262_42207413 | 2.91 |
MRPS10 |
mitochondrial ribosomal protein S10 |
21734 |
0.17 |
chr1_218635811_218635962 | 2.89 |
C1orf143 |
chromosome 1 open reading frame 143 |
47552 |
0.16 |
chr19_3054851_3055002 | 2.89 |
AC005944.2 |
|
2018 |
0.21 |
chr1_19225906_19226116 | 2.87 |
ENSG00000221662 |
. |
2369 |
0.22 |
chr9_137444423_137444866 | 2.87 |
COL5A1 |
collagen, type V, alpha 1 |
88976 |
0.08 |
chr2_113649472_113649623 | 2.86 |
IL37 |
interleukin 37 |
21001 |
0.16 |
chr15_86006680_86006837 | 2.85 |
ENSG00000251891 |
. |
73643 |
0.09 |
chr16_8958042_8958377 | 2.85 |
CARHSP1 |
calcium regulated heat stable protein 1, 24kDa |
2575 |
0.18 |
chr7_75024790_75024951 | 2.84 |
TRIM73 |
tripartite motif containing 73 |
33 |
0.81 |
chr7_92251417_92251760 | 2.84 |
FAM133B |
family with sequence similarity 133, member B |
31880 |
0.18 |
chr1_33793881_33794032 | 2.84 |
ENSG00000266239 |
. |
4137 |
0.14 |
chr16_75278877_75279029 | 2.83 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
2353 |
0.21 |
chr4_153770648_153770924 | 2.83 |
ENSG00000252375 |
. |
51332 |
0.13 |
chr4_89528122_89528353 | 2.81 |
HERC3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
1292 |
0.44 |
chr14_23318302_23318666 | 2.78 |
ENSG00000212335 |
. |
3453 |
0.1 |
chr14_104007312_104007463 | 2.77 |
ENSG00000252469 |
. |
9295 |
0.08 |
chr1_145543308_145543459 | 2.77 |
RP11-315I20.3 |
|
1154 |
0.3 |
chr6_170541741_170541892 | 2.76 |
RP5-1086L22.1 |
|
29841 |
0.17 |
chr8_32411749_32411900 | 2.76 |
NRG1 |
neuregulin 1 |
5579 |
0.33 |
chr21_43202896_43203047 | 2.74 |
RIPK4 |
receptor-interacting serine-threonine kinase 4 |
15705 |
0.17 |
chr11_94483644_94484054 | 2.73 |
RP11-867G2.8 |
|
10328 |
0.22 |
chr17_40820130_40820281 | 2.73 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
8764 |
0.08 |
chr8_28246346_28246638 | 2.72 |
ZNF395 |
zinc finger protein 395 |
2509 |
0.22 |
chr20_1796404_1796650 | 2.71 |
SIRPA |
signal-regulatory protein alpha |
78627 |
0.09 |
chr22_39844730_39844881 | 2.70 |
MGAT3 |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
8544 |
0.15 |
chr1_184923244_184923895 | 2.70 |
FAM129A |
family with sequence similarity 129, member A |
20113 |
0.22 |
chr6_2008574_2008725 | 2.70 |
GMDS |
GDP-mannose 4,6-dehydratase |
167576 |
0.04 |
chr16_87338376_87338735 | 2.69 |
ENSG00000239186 |
. |
9771 |
0.11 |
chr6_119815193_119815487 | 2.69 |
MAN1A1 |
mannosidase, alpha, class 1A, member 1 |
144414 |
0.05 |
chr11_17808780_17808931 | 2.69 |
KCNC1 |
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
51335 |
0.13 |
chr9_113510651_113510802 | 2.68 |
MUSK |
muscle, skeletal, receptor tyrosine kinase |
26901 |
0.24 |
chr1_35149062_35149213 | 2.68 |
ENSG00000207941 |
. |
13842 |
0.2 |
chr14_72064329_72064928 | 2.67 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
323 |
0.94 |
chr11_33714452_33714603 | 2.67 |
RP4-541C22.5 |
|
3720 |
0.2 |
chr10_12284000_12284326 | 2.67 |
RP11-186N15.3 |
|
3994 |
0.17 |
chr9_117039087_117039238 | 2.65 |
ORM1 |
orosomucoid 1 |
46174 |
0.13 |
chr1_231517642_231517793 | 2.65 |
SPRTN |
SprT-like N-terminal domain |
42544 |
0.12 |
chr2_70753439_70753590 | 2.64 |
TGFA |
transforming growth factor, alpha |
27108 |
0.17 |
chr5_134774453_134774604 | 2.63 |
C5orf20 |
chromosome 5 open reading frame 20 |
8510 |
0.14 |
chr11_96059313_96059571 | 2.63 |
ENSG00000266192 |
. |
15160 |
0.19 |
chr19_43437777_43438099 | 2.63 |
PSG6 |
pregnancy specific beta-1-glycoprotein 6 |
14223 |
0.2 |
chr7_2019784_2019935 | 2.62 |
MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
567 |
0.84 |
chr12_6233975_6234126 | 2.62 |
VWF |
von Willebrand factor |
209 |
0.94 |
chr5_77178382_77178545 | 2.62 |
TBCA |
tubulin folding cofactor A |
13859 |
0.29 |
chr9_139117754_139118099 | 2.62 |
QSOX2 |
quiescin Q6 sulfhydryl oxidase 2 |
1203 |
0.46 |
chr6_82472039_82472249 | 2.62 |
ENSG00000206886 |
. |
1597 |
0.4 |
chr5_135006897_135007048 | 2.61 |
ENSG00000238393 |
. |
41933 |
0.15 |
chr15_89922861_89923012 | 2.61 |
ENSG00000207819 |
. |
11688 |
0.19 |
chr8_141728123_141728274 | 2.59 |
PTK2 |
protein tyrosine kinase 2 |
51 |
0.98 |
chr4_1760251_1760414 | 2.58 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
30201 |
0.12 |
chr20_25208276_25208481 | 2.58 |
AL035252.1 |
HCG2018895; Uncharacterized protein |
1008 |
0.49 |
chr1_17252184_17252335 | 2.58 |
CROCC |
ciliary rootlet coiled-coil, rootletin |
3009 |
0.2 |
chr17_11943811_11943962 | 2.55 |
ENSG00000252707 |
. |
3932 |
0.21 |
chr11_15923291_15923597 | 2.54 |
CTD-3096P4.1 |
|
121292 |
0.06 |
chr1_55037377_55037528 | 2.54 |
ACOT11 |
acyl-CoA thioesterase 11 |
23551 |
0.14 |
chr13_78492676_78492827 | 2.54 |
EDNRB |
endothelin receptor type B |
194 |
0.91 |
chr8_96237601_96237983 | 2.53 |
C8orf37 |
chromosome 8 open reading frame 37 |
43637 |
0.17 |
chr7_151385205_151385463 | 2.52 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
48015 |
0.15 |
chr17_45711384_45711535 | 2.52 |
RP11-580I16.2 |
|
2457 |
0.21 |
chr1_15756366_15756604 | 2.51 |
CTRC |
chymotrypsin C (caldecrin) |
8450 |
0.14 |
chr7_21954491_21954642 | 2.50 |
CDCA7L |
cell division cycle associated 7-like |
10689 |
0.28 |
chr1_11799753_11799904 | 2.50 |
AGTRAP |
angiotensin II receptor-associated protein |
3596 |
0.15 |
chr12_53272359_53272510 | 2.48 |
KRT8 |
keratin 8 |
23297 |
0.11 |
chr3_46264039_46264203 | 2.48 |
CCR1 |
chemokine (C-C motif) receptor 1 |
14234 |
0.2 |
chr8_98847352_98847503 | 2.48 |
MATN2 |
matrilin 2 |
33641 |
0.16 |
chr8_143875672_143875823 | 2.47 |
LY6D |
lymphocyte antigen 6 complex, locus D |
7739 |
0.1 |
chr6_89744709_89744911 | 2.46 |
ENSG00000223001 |
. |
28599 |
0.13 |
chr5_176795562_176795713 | 2.45 |
RGS14 |
regulator of G-protein signaling 14 |
1693 |
0.2 |
chr17_39114750_39114901 | 2.45 |
KRT39 |
keratin 39 |
8319 |
0.08 |
chr13_114540098_114540530 | 2.44 |
GAS6 |
growth arrest-specific 6 |
1297 |
0.5 |
chr1_109740426_109740857 | 2.44 |
ENSG00000238310 |
. |
9829 |
0.15 |
chr5_135348000_135348398 | 2.43 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
16385 |
0.2 |
chr18_56422249_56422599 | 2.42 |
RP11-126O1.4 |
|
2462 |
0.27 |
chr4_184051870_184052021 | 2.42 |
WWC2 |
WW and C2 domain containing 2 |
31300 |
0.15 |
chr2_99525021_99525400 | 2.42 |
KIAA1211L |
KIAA1211-like |
226 |
0.95 |
chr5_149872214_149872365 | 2.41 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
5051 |
0.2 |
chr1_234793333_234793503 | 2.41 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
48147 |
0.14 |
chr1_181002368_181002929 | 2.41 |
MR1 |
major histocompatibility complex, class I-related |
419 |
0.83 |
chr22_20887761_20888231 | 2.41 |
MED15 |
mediator complex subunit 15 |
9434 |
0.12 |
chr2_173095900_173096051 | 2.41 |
ENSG00000238572 |
. |
75127 |
0.1 |
chr10_102773281_102773564 | 2.40 |
PDZD7 |
PDZ domain containing 7 |
5204 |
0.11 |
chr22_46403312_46403647 | 2.40 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
30470 |
0.1 |
chr8_6405745_6405896 | 2.40 |
ANGPT2 |
angiopoietin 2 |
14745 |
0.26 |
chr20_10615339_10615490 | 2.39 |
JAG1 |
jagged 1 |
27740 |
0.21 |
chr22_40402746_40403019 | 2.39 |
FAM83F |
family with sequence similarity 83, member F |
2810 |
0.25 |
chr15_65138775_65139098 | 2.38 |
AC069368.3 |
Uncharacterized protein |
4789 |
0.15 |
chr4_90741767_90741918 | 2.38 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
14989 |
0.21 |
chr22_37960029_37960180 | 2.38 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
309 |
0.83 |
chr5_169371262_169371413 | 2.38 |
FAM196B |
family with sequence similarity 196, member B |
36407 |
0.2 |
chr11_45095116_45095267 | 2.38 |
PRDM11 |
PR domain containing 11 |
20373 |
0.26 |
chr6_152238733_152239011 | 2.38 |
ESR1 |
estrogen receptor 1 |
37080 |
0.21 |
chr4_157692638_157692789 | 2.37 |
RP11-154F14.2 |
|
69798 |
0.11 |
chr3_15482456_15482607 | 2.36 |
EAF1-AS1 |
EAF1 antisense RNA 1 |
430 |
0.46 |
chr1_208381209_208381624 | 2.36 |
PLXNA2 |
plexin A2 |
36249 |
0.24 |
chr22_41993610_41993761 | 2.36 |
PMM1 |
phosphomannomutase 1 |
7791 |
0.12 |
chr2_43382863_43383014 | 2.36 |
ENSG00000207087 |
. |
64306 |
0.12 |
chr17_48114815_48114966 | 2.36 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
18449 |
0.13 |
chr7_72439829_72440092 | 2.36 |
TRIM74 |
tripartite motif containing 74 |
37 |
0.95 |
chr12_67852075_67852226 | 2.36 |
CAND1 |
cullin-associated and neddylation-dissociated 1 |
159398 |
0.04 |
chr17_55976898_55977179 | 2.35 |
CUEDC1 |
CUE domain containing 1 |
3712 |
0.21 |
chr6_72186724_72186911 | 2.35 |
ENSG00000212099 |
. |
61862 |
0.12 |
chr5_111004274_111004425 | 2.35 |
ENSG00000253057 |
. |
51409 |
0.14 |
chr6_25005495_25005727 | 2.34 |
ENSG00000244618 |
. |
25899 |
0.17 |
chr19_47134249_47134400 | 2.34 |
GNG8 |
guanine nucleotide binding protein (G protein), gamma 8 |
3618 |
0.11 |
chr18_3346083_3346234 | 2.34 |
TGIF1 |
TGFB-induced factor homeobox 1 |
65448 |
0.09 |
chr9_82288636_82288787 | 2.34 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
21203 |
0.3 |
chr12_66408971_66409122 | 2.34 |
ENSG00000251857 |
. |
50955 |
0.12 |
chr2_159992249_159992400 | 2.34 |
ENSG00000202029 |
. |
108670 |
0.07 |
chr2_38402068_38402250 | 2.34 |
ENSG00000199603 |
. |
27602 |
0.19 |
chr9_124511567_124511718 | 2.33 |
DAB2IP |
DAB2 interacting protein |
6578 |
0.28 |
chr7_51207508_51207786 | 2.33 |
COBL |
cordon-bleu WH2 repeat protein |
50993 |
0.18 |
chr22_21367856_21368007 | 2.33 |
P2RX6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
1385 |
0.19 |
chr15_40628103_40628665 | 2.33 |
C15orf52 |
chromosome 15 open reading frame 52 |
1857 |
0.16 |
chr11_33555009_33555254 | 2.33 |
KIAA1549L |
KIAA1549-like |
8487 |
0.28 |
chr16_68692433_68692584 | 2.33 |
RP11-615I2.2 |
|
12437 |
0.13 |
chr4_20626334_20626656 | 2.33 |
SLIT2 |
slit homolog 2 (Drosophila) |
26519 |
0.23 |
chr2_190119137_190119288 | 2.32 |
ENSG00000266817 |
. |
57275 |
0.13 |
chr6_136358585_136358822 | 2.32 |
RP13-143G15.3 |
|
27073 |
0.2 |
chr5_36658199_36658382 | 2.32 |
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
49859 |
0.16 |
chr8_17519663_17519814 | 2.32 |
MTUS1 |
microtubule associated tumor suppressor 1 |
14100 |
0.17 |
chr20_38526086_38526237 | 2.32 |
ENSG00000263518 |
. |
205837 |
0.03 |
chr3_50175821_50175972 | 2.32 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
16582 |
0.12 |
chr22_30648620_30649241 | 2.31 |
LIF |
leukemia inhibitory factor |
6090 |
0.11 |
chr11_13162605_13162756 | 2.31 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
135519 |
0.05 |
chr5_52635996_52636147 | 2.31 |
FST |
follistatin |
140168 |
0.05 |
chrX_53295610_53295761 | 2.30 |
IQSEC2 |
IQ motif and Sec7 domain 2 |
15111 |
0.17 |
chr20_1921808_1921959 | 2.30 |
RP4-684O24.5 |
|
6009 |
0.24 |
chr4_174240436_174240652 | 2.30 |
RP11-798M19.3 |
|
10301 |
0.14 |
chr14_102729440_102729591 | 2.29 |
MOK |
MOK protein kinase |
11374 |
0.18 |
chr1_6419231_6419418 | 2.29 |
ACOT7 |
acyl-CoA thioesterase 7 |
80 |
0.96 |
chr1_207199417_207199625 | 2.27 |
C1orf116 |
chromosome 1 open reading frame 116 |
6571 |
0.14 |
chr5_148532192_148532343 | 2.27 |
ABLIM3 |
actin binding LIM protein family, member 3 |
10657 |
0.19 |
chr5_149919959_149920110 | 2.27 |
ENSG00000239191 |
. |
3217 |
0.23 |
chr1_33195698_33195964 | 2.27 |
RP11-114B7.6 |
|
4993 |
0.16 |
chr1_192677367_192677518 | 2.27 |
RGS13 |
regulator of G-protein signaling 13 |
72160 |
0.11 |
chr21_37116112_37116263 | 2.27 |
ENSG00000211590 |
. |
23174 |
0.26 |
chr9_77678975_77679126 | 2.27 |
NMRK1 |
nicotinamide riboside kinase 1 |
24056 |
0.14 |
chr9_127336792_127336943 | 2.27 |
NR6A1 |
nuclear receptor subfamily 6, group A, member 1 |
21220 |
0.16 |
chr1_17906725_17906876 | 2.26 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
248 |
0.95 |
chr2_119967496_119967647 | 2.26 |
STEAP3 |
STEAP family member 3, metalloreductase |
13813 |
0.19 |
chr7_143110106_143110452 | 2.26 |
EPHA1 |
EPH receptor A1 |
4294 |
0.13 |
chr13_99566346_99566616 | 2.26 |
DOCK9 |
dedicator of cytokinesis 9 |
58243 |
0.13 |
chr22_46505362_46505513 | 2.26 |
ENSG00000198986 |
. |
3192 |
0.13 |
chr1_9653642_9654104 | 2.26 |
TMEM201 |
transmembrane protein 201 |
3082 |
0.26 |
chr5_136481660_136481811 | 2.26 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
167492 |
0.04 |
chr8_143876663_143876814 | 2.26 |
LY6D |
lymphocyte antigen 6 complex, locus D |
8730 |
0.1 |
chr12_54783002_54783412 | 2.26 |
ZNF385A |
zinc finger protein 385A |
1858 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.8 | GO:0018101 | protein citrullination(GO:0018101) |
1.0 | 4.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
1.0 | 2.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.8 | 3.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 2.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.8 | 2.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.8 | 2.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.7 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.7 | 2.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.7 | 2.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 | 2.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.6 | 1.3 | GO:0042637 | catagen(GO:0042637) |
0.6 | 2.5 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.6 | 1.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.6 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.6 | 2.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 4.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.5 | 1.1 | GO:0010193 | response to ozone(GO:0010193) |
0.5 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 2.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 1.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 1.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.5 | 2.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 1.5 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.5 | 1.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.5 | 1.9 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.5 | 1.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 1.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 2.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 3.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 1.8 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 0.9 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 1.3 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.4 | 1.7 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.4 | 0.4 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.4 | 3.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 1.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.9 | GO:0016246 | RNA interference(GO:0016246) |
0.4 | 3.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.4 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 2.9 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.4 | 4.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 1.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 1.7 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.3 | 1.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 1.4 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.3 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.3 | 0.7 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 1.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 1.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 0.6 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 0.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 1.3 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.3 | 0.9 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 1.9 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 0.3 | GO:0032353 | regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.3 | 0.9 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 1.2 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.3 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 0.3 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.3 | 2.0 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.3 | 2.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.3 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 1.7 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.3 | 0.8 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.3 | 0.8 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.3 | 0.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 0.8 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 0.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.8 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 7.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 1.3 | GO:0001878 | response to yeast(GO:0001878) |
0.3 | 1.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 0.5 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.3 | 0.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 2.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 0.8 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 1.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.3 | 0.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.3 | 0.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.3 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 0.3 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.3 | 0.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.3 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 1.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.8 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.3 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 1.0 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.7 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.7 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 0.7 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 1.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 5.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.7 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 0.9 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.5 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 2.1 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.2 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.7 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.7 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 1.8 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.2 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.8 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 1.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.2 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.8 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.2 | 1.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.2 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) metaphase(GO:0051323) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 2.7 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 3.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.4 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 1.2 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 1.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.8 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 1.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.4 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.2 | 0.4 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.2 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.8 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.2 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 0.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.7 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.2 | 0.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.5 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.2 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.4 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.2 | 0.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.5 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 0.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 1.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.5 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.7 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.2 | GO:0060996 | dendritic spine development(GO:0060996) |
0.2 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.3 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 1.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.2 | 0.5 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.2 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 1.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.2 | 0.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 2.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 2.6 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.2 | 0.5 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.2 | GO:0007431 | salivary gland development(GO:0007431) |
0.2 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 2.4 | GO:0072378 | blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.5 | GO:0060592 | mammary gland formation(GO:0060592) |
0.2 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.2 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 2.0 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 2.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.6 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.2 | 0.9 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.9 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.6 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.1 | 0.1 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.7 | GO:0010894 | negative regulation of steroid biosynthetic process(GO:0010894) |
0.1 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.1 | GO:0060405 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) regulation of penile erection(GO:0060405) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.3 | GO:0019730 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.7 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.1 | 0.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.4 | GO:0061383 | trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
0.1 | 0.7 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.5 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 1.0 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.9 | GO:0071331 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 3.0 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.4 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 1.3 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.1 | 0.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.1 | 1.3 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.7 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.8 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.2 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 2.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.2 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.3 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 2.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.9 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.6 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.1 | 0.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0015865 | purine nucleotide transport(GO:0015865) adenine nucleotide transport(GO:0051503) |
0.1 | 0.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.9 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.2 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.1 | 1.4 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.3 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 1.3 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.1 | GO:0072179 | regulation of mesonephros development(GO:0061217) nephric duct formation(GO:0072179) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.8 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 4.4 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.3 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 4.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 0.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.3 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.1 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.8 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.2 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 2.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 4.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 1.3 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.1 | GO:0071322 | cellular response to carbohydrate stimulus(GO:0071322) |
0.1 | 0.2 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 3.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.3 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.8 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.5 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.1 | 0.3 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0097035 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.3 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.1 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.9 | GO:0030335 | positive regulation of cell migration(GO:0030335) positive regulation of cell motility(GO:2000147) |
0.1 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 1.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.3 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:0031033 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.4 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.1 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0032370 | positive regulation of lipid transport(GO:0032370) |
0.1 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.9 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 1.1 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 2.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.3 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.1 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.3 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 6.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.5 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 1.2 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.1 | 0.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 5.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 2.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.4 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.5 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 1.6 | GO:0007623 | circadian rhythm(GO:0007623) |
0.1 | 0.1 | GO:0045007 | depurination(GO:0045007) |
0.1 | 1.6 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 1.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 2.3 | GO:0007565 | female pregnancy(GO:0007565) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.8 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 3.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0010171 | body morphogenesis(GO:0010171) |
0.1 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 1.7 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0048670 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.1 | 5.1 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 1.9 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.2 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.9 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.8 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 1.1 | GO:0016101 | retinoid metabolic process(GO:0001523) diterpenoid metabolic process(GO:0016101) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 2.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.1 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.2 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.1 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.1 | GO:0060986 | endocrine hormone secretion(GO:0060986) |
0.1 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.1 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0006303 | non-recombinational repair(GO:0000726) double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.3 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 3.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 1.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 1.6 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.3 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.4 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.2 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.4 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.9 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 1.1 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.3 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.4 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.1 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.0 | 0.4 | GO:0007292 | female gamete generation(GO:0007292) |
0.0 | 0.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.2 | GO:1901976 | regulation of spindle checkpoint(GO:0090231) regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 1.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.5 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.3 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.1 | GO:0043558 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 3.2 | GO:0001525 | angiogenesis(GO:0001525) |
0.0 | 0.1 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 1.0 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 1.8 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.2 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.0 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.0 | 0.6 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 4.3 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 3.9 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.0 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0002064 | epithelial cell development(GO:0002064) |
0.0 | 0.0 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.8 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.2 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
0.0 | 0.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.3 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.7 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 1.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.3 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.0 | 0.1 | GO:0090025 | monocyte chemotaxis(GO:0002548) regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.2 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.3 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 1.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.9 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.4 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 2.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.2 | GO:0010565 | regulation of cellular ketone metabolic process(GO:0010565) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0046660 | female sex differentiation(GO:0046660) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0060415 | muscle tissue morphogenesis(GO:0060415) |
0.0 | 0.0 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.2 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0006863 | purine nucleobase transport(GO:0006863) |
0.0 | 0.0 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) regulation of axon guidance(GO:1902667) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:1902656 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.0 | 0.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.2 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0001707 | mesoderm formation(GO:0001707) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0031644 | regulation of neurological system process(GO:0031644) |
0.0 | 0.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.0 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 1.1 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 1.3 | GO:0016049 | cell growth(GO:0016049) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.0 | GO:0042026 | protein refolding(GO:0042026) chaperone cofactor-dependent protein refolding(GO:0070389) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 2.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 2.1 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.3 | 2.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 2.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.7 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.2 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 7.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.2 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 3.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.5 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 2.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 0.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 12.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 5.7 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.9 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 2.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.0 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 7.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:0009295 | nucleoid(GO:0009295) |
0.1 | 0.4 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 5.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 3.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.6 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 3.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 21.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 5.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 2.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.8 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.7 | GO:0031674 | I band(GO:0031674) |
0.1 | 1.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 7.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 4.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 3.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.1 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 1.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 5.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 20.0 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 5.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 3.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.2 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.2 | GO:0032806 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 4.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.4 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.8 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 1.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 5.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 6.5 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 3.0 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.5 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 51.9 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 6.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 3.0 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 1.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 3.9 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 22.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.5 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0001940 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.0 | 2.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 3.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 2.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.8 | 3.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.7 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.9 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.6 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 2.4 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.6 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 1.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 2.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.5 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.5 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 1.4 | GO:0019863 | IgE binding(GO:0019863) |
0.5 | 2.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.4 | 2.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 1.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 3.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.4 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 2.0 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 3.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 2.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 0.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 0.9 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 5.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.3 | 1.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.3 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 1.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 2.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 3.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 8.6 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.3 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.2 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 3.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.6 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 3.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 3.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 1.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 2.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.5 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.2 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.2 | 2.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.6 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 2.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.6 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.0 | GO:0043395 | proteoglycan binding(GO:0043394) heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 1.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 1.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 7.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 4.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 2.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.4 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 1.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.6 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 2.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.6 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 2.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 5.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 6.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 2.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.8 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 4.2 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 3.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 8.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 3.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.9 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 1.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 4.2 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.4 | GO:0001067 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
0.1 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 6.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.5 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 3.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 1.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.4 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 4.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 1.1 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.5 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0016933 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 3.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 2.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 2.0 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 7.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.5 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 10.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.4 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 3.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 3.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 5.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 3.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 3.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 9.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 3.9 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 20.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 7.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 8.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 8.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 10.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 9.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 5.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 7.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 3.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 26.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 5.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 4.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 4.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 6.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 2.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 9.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 8.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 3.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 4.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 0.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 4.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 4.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 5.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 1.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 11.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 2.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 2.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 1.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 4.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 3.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.2 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 9.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.3 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 4.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 5.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.5 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 2.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 4.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 7.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 2.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 1.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 3.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 5.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 2.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.0 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 2.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |